ADHD related Press Releases
FDA Issues Safety Communication about an Ongoing Review of Stimulant Medications Used in Children with ADHD
For Immediate Release: June 15, 2009 FDA Issues Safety Communication about an Ongoing Review of Stimulant Medications Used in Children with ADHD There may be an association between the use of
... Read more...PRESS RELEASE: AHRQ and FDA to Collaborate in Largest Study Ever of Possible Heart Risks With ADHD Medications
AHRQ and FDA to Collaborate in Largest Study Ever of Possible Heart Risks With ADHD Medications Two U.S. Department of Health and Human Services agencies will collaborate in the most comprehensive... Read more...
FDA STATEMENT: AHRQ and FDA to Collaborate in Largest Study Ever of Possible Heart Risks With ADHD Medications
AHRQ and FDA to Collaborate in Largest Study Ever of Possible Heart Risks With ADHD Medications Two U.S. Department of Health and Human Services agencies will collaborate in the most comprehensive... Read more...
Paid Research Reports
- The Top 10 Biosimilar Players: Positioning, performance and SWOT analyses
- New Approaches to Pharma R&D: Evolving strategies to rejuvenate R&D efficiency
- Stakeholder Opinions: Vaccine antigen delivery technologies - Molecular systems to open new markets
- The Top 10 Contract Research Organizations
- Stakeholder Opinions: Vaccine administration technologies - Beyond needles
- Future Pharmaceutical Industry Trends: Long-term opportunities tempered by short-term challenges
